U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 73

1.
Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer–Associated Germline Pathogenic Variants in Mexico
Fernanda Mesa-Chavez, Yanin Chavarri-Guerra, Dione Aguilar-y-Mendez, Andrea Becerril-Gaitan, Bryan F. Vaca-Cartagena, Araceli Carrillo-Bedoya, Salvador Santiesteban-González, Alejandro Aranda-Gutierrez, Andrés Rodríguez-Faure, Daniela Obregon-Leal, Gregorio Quintero-Beuló, Jose L. Rodriguez-Olivares, Melina Miaja, Jeffrey N. Weitzel, Cynthia Villarreal-Garza
JCO Glob Oncol. 2024; 10: e2300417. Published online 2024 Apr 18. doi: 10.1200/GO.23.00417
PMCID:
PMC11191870
AbstractArticlePDF–468K
2.
Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer
Neelam V. Desai, Elizabeth D. Barrows, Sarah M. Nielsen, Kathryn E. Hatchell, Michael J. Anderson, Eden V. Haverfield, Blanca Herrera, Edward D. Esplin, Anneke Lucassen, Nadine M. Tung, Claudine Isaacs
JCO Precis Oncol. 2023; 7: e2200695. Published online 2023 Aug 3. doi: 10.1200/PO.22.00695
PMCID:
PMC10581610
AbstractArticlePDF–417K
3.
Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome
Po-Han Lin, Yun-Wen Tien, Wen-Fang Cheng, Ying-Cheng Chiang, Chien-Huei Wu, Karen Yang, Chiun-Sheng Huang
J Gynecol Oncol. 2023 Sep; 34(5): e66. Published online 2023 May 2. doi: 10.3802/jgo.2023.34.e66
PMCID:
PMC10482589
AbstractArticlePDF–1.9M
4.
PALB2 germline mutations in a large cohort of Middle Eastern breast-ovarian cancer patients
Abdul K. Siraj, Rong Bu, Sandeep Kumar Parvathareddy, Kaleem Iqbal, Saud Azam, Zeeshan Qadri, Maha Al-Rasheed, Wael Haqawi, Mark Diaz, Ingrid G. Victoria, Ismail A. Al-Badawi, Asma Tulbah, Fouad Al-Dayel, Dahish Ajarim, Khawla S. Al-Kuraya
Sci Rep. 2023; 13: 7666. Published online 2023 May 11. doi: 10.1038/s41598-023-34693-9
PMCID:
PMC10175539
AbstractArticlePDF–837K
5.
Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes
Allison W. Kurian, Paul Abrahamse, Kevin C. Ward, Ann S. Hamilton, Dennis Deapen, Jonathan S. Berek, Lily Hoang, Amal Yussuf, Jill Dolinsky, Krystal Brown, Thomas Slavin, Timothy P. Hofer, Steven J. Katz
JCO Precis Oncol. 2021; 5: PO.21.00261. Published online 2021 Dec 22. doi: 10.1200/PO.21.00261
PMCID:
PMC8710333
AbstractArticlePDF–201K
6.
Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer
Emma R. Woodward, Elke M. van Veen, Claire Forde, Elaine F. Harkness, Helen J. Byers, Jamie M. Ellingford, George J. Burghel, Helene Schlech, Naomi L. Bowers, Andrew J. Wallace, Sacha J. Howell, Anthony Howell, Fiona Lalloo, William G. Newman, Miriam J. Smith, D. Gareth Evans
Genet Med. 2021; 23(10): 1969–1976. Published online 2021 Jun 10. doi: 10.1038/s41436-021-01234-6
PMCID:
PMC8486655
AbstractArticlePDF–466K
7.
Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions
Chiara Guglielmi, Rosa Scarpitta, Gaetana Gambino, Eleonora Conti, Francesca Bellè, Mariella Tancredi, Tiziana Cervelli, Elisabetta Falaschi, Cinzia Cosini, Paolo Aretini, Caterina Congregati, Marco Marino, Margherita Patruno, Brunella Pilato, Francesca Spina, Luisa Balestrino, Elena Tenedini, Ileana Carnevali, Laura Cortesi, Enrico Tagliafico, Maria Grazia Tibiletti, Stefania Tommasi, Matteo Ghilli, Caterina Vivanet, Alvaro Galli, Maria Adelaide Caligo
Int J Mol Sci. 2021 Jul; 22(14): 7693. Published online 2021 Jul 19. doi: 10.3390/ijms22147693
PMCID:
PMC8305371
AbstractArticlePDF–1.9M
8.
Cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness
Leann A Lovejoy, LTC Clesson E Turner, COL Craig D Shriver, Rachel E Ellsworth
Mil Med. 2021 Jul-Aug; 186(7-8): e737–e742. Published online 2021 Jul 1. doi: 10.1093/milmed/usaa485
PMCID:
PMC8246613
AbstractArticlePDF–348K
9.
Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia
Dorra Ben Ayed-Guerfali, Wala Ben Kridis-Rejab, Nihel Ammous-Boukhris, Wajdi Ayadi, Slim Charfi, Afef Khanfir, Tahia Sellami-Boudawara, Mounir Frikha, Jamel Daoud, Raja Mokdad-Gargouri
J Transl Med. 2021; 19: 108. Published online 2021 Mar 16. doi: 10.1186/s12967-021-02772-y
PMCID:
PMC7962399
AbstractArticlePDF–1.0M
10.
A regional population‐based hereditary breast cancer screening tool in Italy: First 5‐year results
Laura Cortesi, Bruna Baldassarri, Stefano Ferretti, Elisabetta Razzaboni, Mariangela Bella, Lauro Bucchi, Debora Canuti, Pierandrea De Iaco, Giorgio De Santis, Fabio Falcini, Vania Galli, Lea Godino, Maurizio Leoni, Anna Myriam Perrone, Marco Pignatti, Gianni Saguatti, Donatella Santini, Priscilla Sassoli de'Bianchi, Federica Sebastiani, Mario Taffurelli, Giovanni Tazzioli, Daniela Turchetti, Claudio Zamagni, Carlo Naldoni
Cancer Med. 2020 Apr; 9(7): 2579–2589. Published online 2020 Feb 11. doi: 10.1002/cam4.2824
PMCID:
PMC7131858
AbstractArticlePDF–304K
11.
Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer
Bo Chen, Guochun Zhang, Xuerui Li, Chongyang Ren, Yulei Wang, Kai Li, Hsiaopei Mok, Li Cao, Lingzhu Wen, Minghan Jia, Cheukfai Li, Liping Guo, Guangnan Wei, Jiali Lin, Yingzi Li, Yuchen Zhang, Han Han-Zhang, Jing Liu, Analyn Lizaso, Ning Liao
Aging (Albany NY) 2020 Feb 29; 12(4): 3140–3155. Published online 2020 Feb 24. doi: 10.18632/aging.102783
PMCID:
PMC7066887
AbstractArticlePDF–1.7M
12.
Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations
Valentina Vysotskaia, K. Eerik Kaseniit, Leslie Bucheit, Kaylene Ready, Kristin Price, Katherine Johansen Taber
Cancer. 2020 Feb 1; 126(3): 549–558. Published online 2019 Nov 4. doi: 10.1002/cncr.32572
PMCID:
PMC7003834
AbstractArticlePDF–253K
13.
BRCA1 and BRCA2 Testing through Next Generation Sequencing in a Small Cohort of Italian Breast/Ovarian Cancer Patients: Novel Pathogenic and Unknown Clinical Significance Variants
Paola Concolino, Gianfranco Gelli, Roberta Rizza, Alessandra Costella, Giovanni Scambia, Ettore Capoluongo
Int J Mol Sci. 2019 Jul; 20(14): 3442. Published online 2019 Jul 12. doi: 10.3390/ijms20143442
PMCID:
PMC6678297
AbstractArticlePDF–7.5M
14.
Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan
Muhammad Usman Rashid, Faiz Ali Khan, Noor Muhammad, Asif Loya, Ute Hamann
Cancer Res Treat. 2019 Jul; 51(3): 992–1000. Published online 2018 Oct 11. doi: 10.4143/crt.2018.356
PMCID:
PMC6639217
AbstractArticlePDF–918K
15.
Functional evaluation of variants of unknown significance in the BRCA2 gene identified in genetic testing
Marie Heczkova, Eva Machackova, Peter Macinga, Eike Gallmeier, Monika Cahova, Julius Spicak, Milan Jirsa, Lenka Foretova, Tomas Hucl
Cancer Biol Ther. 2019; 20(5): 633–641. Published online 2019 Jan 13. doi: 10.1080/15384047.2018.1550566
PMCID:
PMC6606029
AbstractArticlePDF–1.3M
16.
Legacies and Relationships: Diverse Social Networks and BRCA1/2 Risk Management Decisions and Actions
Anne L. Ersig, Allison Werner-Lin, Lindsey Hoskins, Jennifer Young, Jennifer T. Loud, June Peters, Mark H. Greene
J Fam Nurs. Author manuscript; available in PMC 2019 Jun 18.
Published in final edited form as: J Fam Nurs. 2019 Feb; 25(1): 28–53. Published online 2018 Dec 12. doi: 10.1177/1074840718815844
PMCID:
PMC6581043
AbstractArticlePDF–225K
17.
Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes
Jiayu Wang, Weiwei Li, Yujian Shi, Yan Huang, Tao Sun, Lili Tang, Qing Lu, Qiumo Lei, Ning Liao, Feng Jin, Hui Li, Tao Huang, Jun Qian, Danmei Pang, Shusen Wang, Peizhi Fan, Xinhong Wu, Ying Lin, Haiyan Qin, Binghe Xu
Cancer Med. 2019 May; 8(5): 2074–2084. Published online 2019 Apr 13. doi: 10.1002/cam4.2093
PMCID:
PMC6536923
AbstractArticlePDF–1.1M
18.
Cancer genetic health communication in families tested for hereditary breast/ovarian cancer risk: a qualitative investigation of impact on children’s genetic health literacy and psychosocial adjustment
Kenneth P Tercyak, Suzanne M Bronheim, Nicole Kahn, Hillary A Robertson, Bruno J Anthony, Darren Mays, Suzanne C O’Neill, Susan K Peterson, Susan Miesfeldt, Beth N Peshkin, Tiffani A DeMarco
Transl Behav Med. 2019 Jun; 9(3): 493–503. Published online 2019 May 16. doi: 10.1093/tbm/ibz012
PMCID:
PMC6520800
AbstractArticlePDF–173K
19.
Painting a portrait: Analysis of national health survey data for cancer genetic counseling
Monica H. Stamp, Ora K. Gordon, Christopher P. Childers, Kimberly K. Childers
Cancer Med. 2019 Mar; 8(3): 1306–1314. Published online 2019 Feb 7. doi: 10.1002/cam4.1864
PMCID:
PMC6434212
AbstractArticlePDF–211K
20.
Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer
Paula Paulo, Sofia Maia, Carla Pinto, Pedro Pinto, Augusta Monteiro, Ana Peixoto, Manuel R. Teixeira
PLoS Genet. 2018 Apr; 14(4): e1007355. Published online 2018 Apr 16. doi: 10.1371/journal.pgen.1007355
PMCID:
PMC5919682
AbstractArticlePDF–2.3M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center